Yes. On July 3,2017 the U.S. FDA granted DigniCap clearance to reduce the likelihood of chemotherapy-induced alopecia in cancer patients with solid tumors, so it is now cleared for both men and women. DigniCap was also the first scalp cooling device to receive FDA clearance, which was granted December 8, 2015 for use by women with Breast Cancer undergoing chemotherapy.